This article is a correction to:
Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis
Xiangzhi Song1†
Lushun Zhang- 1School of Clinical Medicine, Chengdu Medical College, Chengdu, China
- 2Department of Pathology, the Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, China
- 3Development and Regeneration Key Laboratory of Sichuan Province, Department of Neurobiology, Chengdu Medical College, Chengdu, China
- 4Department of Pathology and Pathophysiology, Chengdu Medical College, Chengdu, China
A Corrigendum on
Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis
by Song X, Li X, Tan Z and Zhang L (2024). Front. Oncol. 14:1327851. doi: 10.3389/fonc.2024.1327851
In the published article, there was an error. We have improperly phrased the first sentence of the abstract’s background and the first sentence of the article’s introduction.
Corrections have been made to Abstract and Introduction. These sentences previously stated:
(1) “Cervical cancer is currently the second leading cause of death among women.”
(2) “Globally, cervical cancer is the second most common type of cancer among women and the fourth leading cause of cancer-related deaths among women.”
The corrected sentences appear below: “Cervical cancer is currently the second leading cause of cancer death among women from developing countries (1).”; “Globally, cervical cancer is the fourth most common type of cancer among women and the second leading cause of cancer-related deaths among women from developing countries (1, 2).”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Martínez-Rodríguez F, Limones-González JE, Mendoza-Almanza B, Esparza-Ibarra EL, Gallegos-Flores PI, Ayala-Luján JL, et al. Understanding cervical cancer through proteomics. Cells. (2021) 10. doi: 10.3390/cells10081854
Keywords: nanotechnology, cervical cancer, bibliometrics, nanoparticles, drug deliver
Citation: Song X, Li X, Tan Z and Zhang L (2024) Corrigendum: Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis. Front. Oncol. 14:1395166. doi: 10.3389/fonc.2024.1395166
Received: 03 March 2024; Accepted: 12 March 2024;
Published: 21 March 2024.
Edited and Reviewed by:
Qitong Huang, Gannan Medical University, ChinaCopyright © 2024 Song, Li, Tan and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhiwei Tan, 4658624@qq.com; Lushun Zhang, zhangls2012@cmc.edu.cn
†These authors have contributed equally to this work